Forge Therapeutics

About:

Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.

Website: http://www.forgetherapeutics.com/

Twitter/X: ForgeZak

Top Investors: Evotec, National Institute of Allergy and Infectious Diseases, Tech Coast Angels, WS Investments, MP Healthcare Venture Management

Description:

Forge Therapeutics, Inc is a biotechnology company discovering and developing novel therapeutics using an innovative chemistry platform targeting metalloproteins. Forge uses a proprietary approach combining bioinorganic (study of metals in biology) and medicinal chemistry to generate selective inhibitors of this large class of targets.

Total Funding Amount:

$29.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Contact Email:

Info(AT)ForgeTherapeutics.com

Founders:

David Puerta, Seth Cohen, Zachary Zimmerman

Number of Employees:

11-50

Last Funding Date:

2019-01-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai